James Groves
Keine laufenden Positionen mehr
Profil
James Groves served as Director at Caristo Diagnostics Ltd.
from 2018 to 2022.
Prior to that, he worked as Principal Licensing & Ventures Manager at Oxford University Innovation Ltd.
Mr. Groves received his graduate degree from the University of Oxford in 2006 and his undergraduate degree from The University of Nottingham in 2005.
Ehemalige bekannte Positionen von James Groves
Unternehmen | Position | Ende |
---|---|---|
Caristo Diagnostics Ltd.
Caristo Diagnostics Ltd. Medical SpecialtiesHealth Technology Caristo Diagnostics Ltd. engages in the development of cardiovascular diagnostic tools. The company was founded by Charalambos Antoniades on June 22, 2018 and is headquartered in Oxford, the United Kingdom. | Direktor/Vorstandsmitglied | 01.01.2022 |
Oxford University Innovation Ltd.
Oxford University Innovation Ltd. Investment ManagersFinance Oxford University Innovation Ltd (Oxford University Innovation) is a venture capital subsidiary of University of Oxford founded in 1987 and spun out in 2010. The firm is headquartered in London, United Kingdom. | Private Equity Investor | - |
Ausbildung von James Groves
University of Oxford | Graduate Degree |
The University of Nottingham | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Oxford University Innovation Ltd.
Oxford University Innovation Ltd. Investment ManagersFinance Oxford University Innovation Ltd (Oxford University Innovation) is a venture capital subsidiary of University of Oxford founded in 1987 and spun out in 2010. The firm is headquartered in London, United Kingdom. | Finance |
Caristo Diagnostics Ltd.
Caristo Diagnostics Ltd. Medical SpecialtiesHealth Technology Caristo Diagnostics Ltd. engages in the development of cardiovascular diagnostic tools. The company was founded by Charalambos Antoniades on June 22, 2018 and is headquartered in Oxford, the United Kingdom. | Health Technology |